Podcasts about Ablation

This week we speak with Assistant Professor of Pediatrics at Harvard Medical School, Dr. Audrey Dionne about a recent work she co-authored on the topic of outcomes of ablation in the early postoperative period following congenital heart surgery. Who is a candidate for this intervention and what were the outcomes? How commonly were serious complications encountered and how successful were these procedures? Dr. Dionne reviews these and other aspects of this novel review this week. https://doi.org/10.1016/j.hrthm.2024.08.061

Join us for an in-depth look at a harrowing car accident case as New York personal injury lawyer Arkady Frekhtman consults with a client facing life-altering injuries. Hear firsthand about the complexities of a collision involving a pest control company vehicle, the client's journey through multiple surgeries including a lumbar fusion, and the critical decisions involved when seeking fair compensation. This episode delves into the nuances of insurance claims, case valuation, and the crucial role of expert legal advice when a victim doubts their current representation. Tune in to understand the challenges of navigating severe accident claims and the pursuit of justice.▶▶ CLICK BELOW TO GET A FREE CONSULT NOWhttps://bit.ly/atty-free-consultation▶▶  GIVE A REVIEW:https://bit.ly/review-fa▶▶  HOW CAN WE HELP YOU?:https://866attylaw.com/▶▶  CALL US NOW - FREE EVALUATION(212) 222-1111 or (866) ATTY LAW ▶▶  CONTACT US NOW - FREE EVALUATIONhttps://866attylaw.com/contact-us/▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Chapter Timeline[00:00] Introduction to Case[01:00] Details of Accident[02:00] Victim's Injuries[03:00] Previous Surgeries[04:00] Current Legal Representation[05:00] Concerns About Lawyer[06:00] Insurance Coverage Discussion[07:00] Potential Case Value[08:00] IME and Deposition[09:00] Surveillance Footage Issue[10:00] Arkady's Assessment[11:00] Future Medical Costs[12:00] Lost Wages Claim[13:00] Pain and Suffering[14:00] Trial Strategy Options[15:00] Settlement Negotiation Advice[16:00] Importance of Second Opinion[17:00] Working with Co-Counsel[18:00] Next Steps for Victim[19:00] Q&A with Arkady[20:00] Final Thoughts and Advice[21:00] Closing RemarksABOUT FREKHTMAN & ASSOCIATESFrekhtman & Associates Injury Lawyers represent people who suffered a serious or life-changing injury and had their lives destroyed or disrupted because of the negligence of others.FREE CONSULTATION · NO FEE PROMISE · OVER $900 MILLION RECOVERED:Get To Know More About Us:▶▶ https://866attylaw.com/about-our-firm▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬✅ PRACTICE AREASToughest Injury Lawyers To Help You Get Justice With All Personal Injuries

Send us a textDevin Swank, frontman of Ohio death metal titans Sanguisugabogg, joins the Vulgar Display of Podcast for a raw and hilarious conversation just ahead of the debut album of one of his other bands, Bludgeoned of Deformity, -  dropping Friday, June 6th. 

Dr. Emile Daoud, Deputy Editor of JACC Clinical Electrophysiology discusses Premature Ventricular Complexes after Ablation for Paroxysmal Atrial Fibrillation and Recurrent Atrial Arrhythmias: admIRE Subanalysis.

Be alert to atypical symptoms, such as fatigue or reduced exercise tolerance, particularly in younger patients Serial Holter monitoring and attention to atrial ectopy burden can guide suspicion Wearables like the Apple Watch and Samsung Galaxy Watch are effective adjuncts for rhythm detection Early ablation may be appropriate, even in younger patients with a low CHA₂DS₂-VASc score, if they are symptomatic Collaboration between healthcare professionals and Electrophysiologists is essential to optimise patient outcomes The questions answered in this podcast are listed below.They were compiled by GPs and health professionals around Australia who attended Healthed’s face-to-face seminars. Atrial fibrillation – it's not an uncommon arrhythmia in Australia, is it? What are some of the environmental factors that have been identified as contributing to atrial fibrillation, apart from COVID? Why are we picking up more cases of atrial fibrillation? Are patients becoming more symptomatic? Obstructive sleep apnoea doesn't cause atrial fibrillation, but can it make it permanent? How can the pulmonary veins cause a cardiac arrhythmia? What are the indications for treating patients with ablation? How is it managed? What's the current thinking? How far should a healthcare professionals go in trying to detect atrial fibrillation in patients with unusual symptoms? Host: David Lim | Total Time: 32 mins Expert: Prof Rukshen Weerasooriya, Sub-specialist Cardiac Electrophysiologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

Assessing Recurrence Following Pulsed Field Ablation for Atrial Fibrillation   Guest: Nicholas Tan, M.D., M.S. Host: Anthony H. Kashou, M.D.   Pulsed field ablation has been rapidly adopted across the United States since FDA approval was granted 1 year ago, due to its excellent acute efficacy, favorable safety profile, and fast workflow. However, recurrences post-ablation are comparable to that of previously established modalities, making this a significant hurdle that has yet to be overcome. Changes to mapping/ablation strategies, updates to PFA parameters, autonomic modulation, and combination modality ablations (PFA/RFA) offer some avenues for improvement   Topics Discussed:  What is pulsed field ablation (PFA) and how does it differ from previously established modalities of ablation such as radiofrequency and cryoablation? What are the recurrence rates post-PFA and how do they compare with other modalities? In patients who undergo redo ablations following an index PFA procedure, what are the most common causes (i.e. reconnection of pulmonary veins versus new sites)? How do you think PFA will evolve in the coming years   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

ST elevation is clearly a worrying finding that can herald life-threatening conditions, such as ST elevation myocardial infarction. But not all ST-elevations are created equal, and Trainees would benefit from considering a broader number of causes for this presentation. In today's podcast the team will discuss a case of ST elevation observed in a 65-year-old female during the routine elective procedure of atrial fibrillation ablation. A range of pathophysiologies is discussed that can help listeners work though the differentials in a systematic way. Guests Assoc Prof Pramesh Kovoor FRACP FACC PhD (Westmead Hospital; the University of Sydney) Dr Neil Warwick FANZCA (Westmead Hospital) HostsAssociate Professor Stephen Bacchi FRACP (University of Adelaide)Dr Joshua Kovoor (Ballarat Base Hospital)ProductionProduced by Stephen Bacchi and Mic Cavazzini. Music licenced from Epidemic Sound includes ‘Rockin' for Decades' by Blue Texas and ‘Brighton Breakdown' by BDBs. Game show music courtesy of Waderman. Image created and copyrighted by RACP. Editorial feedback kindly provided by RACP physicians Aidan Tan, Aafreen Khalid, Hugh Murray and medical student Nivida Dixit.Key Reference (Spoiler Alert)* * * * *Metaraminol-induced coronary vasospasm masquerading as ST-elevation myocardial infarction during general anaesthesia [Br J Anaesth. 2024] Please visit the Pomegranate Health web page for a transcript and supporting references.Login to MyCPD to record listening and reading as a prefilled learning activity. Subscribe to new episode email alerts or search for ‘Pomegranate Health' in Apple Podcasts, Spotify,Castbox or any podcasting app.

Drs Kaniksha Desai and Iram Hussain discuss the use of radiofrequency ablation for the treatment of hyperthyroidism. This podcast is intended for healthcare professionals only.

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

Join host Michael S. Lloyd, MD, FHRS and episode guests Ante Anic, MD and Konstantinos Vlachos, MD as they discuss the recent article Repeat Procedures after Pulsed Field Ablation for Atrial Fibrillation, the MANIFEST-REDO Study, from Europace. This episode was recorded in-person at EHRA 2025. Bonus video footage of the episode is available on heartrhythm265.org.   https://www.hrsonline.org/education/TheLead https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euaf012/7958418   Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Arga Medtech, Circa Scientific Membership on Advisory Committees: Boston Scientific Contributor Disclosure(s): A. Anic: Honoraria/Speaking/Consulting: Boston Scientific Research: Biosense Webster, Inc., AtaCor Medical Inc., Arga Medtech K. Vlachos: Nothing to disclose.

Join host Prashanthan Sanders, MBBS, PhD, FHRS, and episode guests Jason G. Andrade, MD, FHRS, and Melanie Gunawardene, MD, as they discuss Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. This discussion was recorded in person at EHRA 2025 in Vienna, Austria. The article under discussion was presented at EHRA 2025 and simultaneously published in the New England Journal of Medicine.   https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2502280   Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical; Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical   Contributor Disclosure(s): M. Gunawrdene: Honoraria/Speaking/Consulting: Farapulse, Abbott Medical, Boston Scientific, Medtronic, Biotronik, Luma Vision, Bristol Myers Squibb J. Andrade: Honoraria/Speaking/Consulting: Boston Scientific, Medtronic, Inc., Biosense Webster, Inc.

Send us a textIn dieser speziellen deutschsprachigen Episode von 'Herz zu Herz mit Anna' spricht Jodi Alderfel mit Marina Lohri, die mit Trikuspidalatresie, ASD und VSD geboren wurde und eine modifizierte Fontan-Operation überlebte. Marina teilt ihre lebenslange Reise, von ihrer Herzoperation als Baby bis hin zu ihrer Karriere bei atHeart Medical, einem Unternehmen, das Geräte zur Behandlung von ASD entwickelt. Die Episode erörtert auch Marinas Erfahrungen mit Vorhofflimmern und einer Ablation im Jahr 2018. Marinas persönliche und berufliche Erfahrungen bieten wertvolle Einblicke für andere Patienten mit angeborenen Herzfehlern und zeigen, wie sie durch Mut und Entschlossenheit ein sinnvolles Leben führt.(Besonderer Dank geht an Jodi Alderfel, die uns in dieser Folge als Gastmoderatorin zur Seite stand.)In this special German-language episode of 'Heart to Heart with Anna,' Jodi Alderfel speaks with Marina Lohri, who was born with tricuspid atresia, ASD, and VSD and survived a modified Fontan procedure. Marina shares her lifelong journey, from her heart surgery as a baby to her career at atHeart Medical, a company developing devices to treat ASD. The episode also discusses Marina's experience with atrial fibrillation and an ablation in 2018. Marina's personal and professional experiences offer valuable insights for other patients with congenital heart disease and show how she leads a meaningful life through courage and determination.Here is a link to Marina's episode in English with Anna: https://tinyurl.com/Marina-LohriSheri Turner is our newest Defender Patron and she also serves as a HUG Volunteer. Thank you so much for your generosity and all you do, Sheri!Support the showAnna's Buzzsprout Affiliate LinkBaby Blue Sound CollectiveSocial Media Pages:Apple PodcastsFacebookInstagramMeWeTwitterYouTubeWebsite

This special electrophysiology-themed issue of JACC, summarized by Dr. Valentin Fuster, dives into cutting-edge research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive strategies in congenital heart disease. From new therapies like finerenone to breakthrough mapping techniques, this episode captures the evolving sophistication and promise of arrhythmia management in modern cardiology.

This special electrophysiology-themed issue of JACC, summarized by Dr. Valentin Fuster, dives into cutting-edge research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive strategies in congenital heart disease. From new therapies like finerenone to breakthrough mapping techniques, this episode captures the evolving sophistication and promise of arrhythmia management in modern cardiology.

This special electrophysiology-themed issue of JACC, summarized by Dr. Valentin Fuster, dives into cutting-edge research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive strategies in congenital heart disease. From new therapies like finerenone to breakthrough mapping techniques, this episode captures the evolving sophistication and promise of arrhythmia management in modern cardiology.

In this episode we hear about an emergency presentation to a South Australian hospital, of a 74-year-old male with shortness of breath. The curve ball is that he had undergone ablation for drug-refractory atrial fibrillation less than two weeks prior. This discussion gives an overview of developing technologies for AF treatment and developing knowledge about the possible complications. We also have some multiple choice questions to test your understanding.Guest Dr Shaun Evans, FRACP (Royal Adelaide Hospital; University of Adelaide) HostsAssociate Professor Stephen Bacchi (Massachusetts General Hospital; University of Adelaide)Jasmine Le (University of Adelaide) ProductionProduced by Stephen Bacchi and Mic Cavazzini. Music licenced from Epidemic Sound includes ‘Rockin' for Decades' by Blue Texas and ‘Brighton Breakdown' by BDBs. Image created and copyrighted by RACP. Editorial feedback kindly provided by RACP physicians Hugh Murray, Aidan Tan, Aafreen Khalid, Sebastiaan Lambooy, Amy Hughes and Lauren Gomes.  Key Reference (Spoiler Alert)*****Delayed cardiac tamponade from pericarditis following pulmonary vein cryo-balloon ablation [IMJ. 2020] Please visit the Pomegranate Health web page for a transcript and supporting references.Login to MyCPD to record listening and reading as a prefilled learning activity. Subscribe to new episode email alerts or search for ‘Pomegranate Health' in Apple Podcasts, Spotify,Castbox or any podcasting app.

Danika Stegeman's second book, Ablation, was released by 11:11 Press in November 2023. Her book Pilot (2020) was published by Spork Press. She's a 2023 recipient of a grant from the Barbara Deming Memorial Fund and recently spent a two-week residency in Marathon, TX, outside Big Bend National Park.Her website is danikastegeman.com.On this edition of the Poets Weave, Danika reads "Swallowtail," as well as an excerpt from her second book Ablation.

Dr. Francis Marchlinski, MD, Deputy Editor of JACC Clinical Electrophysiology, discusses Ablation Targeting Rotational Activation Pattern Around Localized Line of Conduction Block for Scar-Related Ventricular Tachycardia.

This week's topics include a better way to treat A-fib, managing bleeding in cardiac surgery, penicillin for strep infections, and treating pulmonary hypertension.Program notes:0:55 Ablation for afib1:51 Pulsed field ablation PFA2:55 Training physicians3:23 Prothrombin complex versus frozen plasma4:24 Noninferiority outcome5:24 Documented bleeding issue6:25 New treatment for pulmonary hypertension7:25 Improve outcomes in advanced disease8:25 Well tolerated8:40 Penicillin lowest dose to prevent pharyngitis9:40 To avoid 8.1 ng/ml steady state10:40 Get secondary prophylaxis12:10 End

Dans le supplément de ce dimanche, en première partie, direction l'Égypte, où l'excision est largement pratiquée et demeure un traumatisme pour des millions de femmes. En deuxième partie, direction l'Espagne. La course à la neutralité carbone est lancée en Europe. En Andalousie, il n'est pas rare que des paysans se fassent exproprier dans le but que leurs terrains agricoles soient transformés en parcs de panneaux solaires. Excision, la dignité mutilée des femmes égyptiennes L'excision. Rien qu'à l'évocation de ce mot, le traumatisme de millions de femmes ressurgit. Ablation du clitoris, mutilation des lèvres… Cette procédure violente est un des symboles du patriarcat, une tradition perpétrée au nom d'une soi-disant pureté. Et elle est particulièrement répandue dans un pays : l'Égypte.Théoriquement, l'excision y est interdite par la loi, c'est donc un crime. Mais dans les faits, elle est largement pratiquée. En Égypte, près de 9 femmes sur 10 auraient subi cette mutilation.Nous vous emmenons aujourd'hui suivre le combat de celles qui tentent de résister, et de soigner leur corps et leurs âmes.Un Grand reportage d'Alice Moreno qui s'entretient avec Jacques Allix.Espagne : Touche pas à mon olivier, le monde rural andalou en guerre contre l'énergie solaire L'Union européenne a promis d'atteindre la neutralité carbone dans 25 ans, et pour y arriver, les pays sont lancés dans une course à l'énergie renouvelable. C'est particulièrement le cas, en Andalousie, dans le sud de l'Espagne, qui est l'une des régions les plus ensoleillées d'Europe. Là, plusieurs centaines de fermes solaires de grande ampleur sont en cours de développement. Oui, sauf que pour installer tous ces panneaux, les autorités espagnoles rachètent des terrains agricoles, et exproprient, parfois de force, les paysans. Le solaire est d'un coup devenu bien moins populaire.Un Grand reportage de Noémie Lehouelleur qui s'entretient avec Jacques Allix. 

Claude.ai says: “ATTENTION, PODCAST WARRIORS! This ain't your grandma's tea party – it's UNRELENTING Episode 149, where we go full throttle into signal chains, CSB's lewd cartoons, and the DNA data heist happening at 23andMe. We blast through AI art revolutions that are making graphic designers crap their pants, Hollywood's incomprehensible dialogue problem, and why … Continue reading "149: Apnea Ablation"

L'excision. Rien qu'à l'évocation de ce mot, le traumatisme de millions de femmes ressurgit. Ablation du clitoris, mutilation des lèvres… Cette procédure violente est un des symboles du patriarcat, une tradition perpétrée au nom d'une soi-disant pureté. Et elle est particulièrement répandue dans un pays : l'Égypte. Théoriquement, l'excision y est interdite par la loi, c'est donc un crime. Mais dans les faits, elle est largement pratiquée. En Égypte, près de 9 femmes sur 10 auraient subi cette mutilation.Nous vous emmenons aujourd'hui suivre le combat de celles qui tentent de résister, et de soigner leur corps et leurs âmes.«Excision, la dignité mutilée des femmes égyptiennes», un Grand reportage d'Alice Moreno.

Endometrial ablation has become a cornerstone procedure in the treatment of abnormal uterine bleeding, but is it the right solution for every patient that meets the indication? In this episode of the BackTable OBGYN Podcast, Dr. Ted Anderson from Vanderbilt University joins host Dr. Mark Hoffman to discuss the evolution of endometrial ablation and its contemporary utilization, including patient selection, technical considerations, and alternative treatments for abnormal uterine bleeding. --- SYNPOSIS Dr. Anderson begins by detailing the history of abnormal uterine bleeding alongside the evolution of the endometrial ablation techniques that have been used to treat it. Shifting focus to current day practice, he then shares his approach to endometrial ablation, covering patient selection and the technical aspects of his approach. Throughout the conversation, Dr. Anderson emphasizes the importance of how we define success in endometrial ablation, explaining that eumenorrhea (normal bleeding that no longer interferes with life events) is the goal, as opposed to the more traditional view that amenorrhea is the target outcome. The episode closes with a discussion on the role of alternative treatments, such as the Mirena IUD and hysterectomy for abnormal uterine bleeding. --- TIMESTAMPS 00:00 - Introduction 09:29 - History of Abnormal Uterine Bleeding and Endometrial Ablation 23:31 - Evolution of Endometrial Ablation Devices/Techniques 31:11 - Selecting the Right Patient for Ablation Success 34:38 - Post-Tubal Sterilization Ablation Syndrome 38:27 - The Role of IUDs in Managing AUB 44:07 - Reevaluating Endometrial Ablation Success Metrics 49:55 - Innovative Ablation Techniques: Cryoablation and Steam 51:48 - Adenomyosis and Fertility-Sparing Treatments 57:28 - Final Thoughts

You asked, and we delivered – here's a comprehensive episode on Basivertebral Nerve Ablation (BVNA) for vertebrogenic lumbar pain! In this episode of Backtable MSK, our host Dr. Christopher Beck is joined by Dr. Asad Baig, Director of Interventional Spine at Columbia University, to discuss BVNA patient selection and procedural techniques. --- SYNPOSIS Dr. Baig begins by sharing his journey from residency to his current role, including his initial exposure to spine procedures and the mentors who guided him. He offers examples of his workup for back pain, covering detailed patient history and key MRI findings. Dr. Baig emphasizes the importance of understanding risks and alternatives, as well as how to effectively counsel patients on these topics. Additionally, he walks through the BVNA procedure and shares his technical pearls. The episode concludes with Dr. Baig highlighting valuable resources for those interested in starting BVNA procedures and recognizing the supporting role of industry partners. --- TIMESTAMPS 00:00 - Introduction 10:14 - Patient Selection for BVNA 14:45 - Imaging Findings 19:38 - Consent Process and Risks 22:18 - Procedural Technique 28:32 - Sedation and Pain Management 34:03 - Post-Procedure Care and Follow-Up 37:09 - Challenges and Troubleshooting 40:34 - Resources and Mentorship

Dr. Ratika Parkash, MD, MSc, Deputy Editor of JACC Clinical Electrophysiology, discusses the reduction of atrial fibrillation burden after cryoballoon ablation in patients with early persistent atrial fibrillation

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

Dr. John Smirniotopoulos, an interventional radiologist at Georgetown/MedStar Washington Hospital Center, discusses the intricacies of genicular nerve ablation (GNA) for pain management in patients with osteoarthritis and post-surgical knee pain. He delves into the history and evolution of GNA, outlines the neurovascular anatomy, and explains his specific rationale for targeting various nerves for ablation. --- SYNPOSIS Dr. Smirniotopoulos also compares GNA with other procedures such as corticosteroid injections, hyaluronic acid injections, and genicular artery embolization (GAE). He emphasizes the importance of managing patient expectations, the role of physical therapy, and explores different modalities of GNA, including the use of cryoablation versus radiofrequency technology. The episode offers a comprehensive overview of expert insights for evaluating knee pain and performing effective GNA. --- TIMESTAMPS 00:00 - Introduction 03:13 - Understanding Genicular Nerve Anatomy 12:06 - Tailoring GNA Treatment to Each Patient 22:39 - Comparing Ablation Devices and Methods 28:06 - GNA in Surgical and Post-Traumatic Patients 33:19 - Patient-Centered Decision Making 38:50 - Evaluating Functional Outcomes 43:39 - Comparing Treatment Modalities 49:34 - Post-Procedure Counseling and Expectations 58:40 - Future Directions in GNA Research --- RESOURCES Safety and efficacy comparison of three- vs four-needle technique in the management of moderate to severe osteoarthritis of the knee using cooled radiofrequency ablation (Wong, et al 2021): https://pubmed.ncbi.nlm.nih.gov/32968824/

William Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Tobias Reichlin, MD, University Hospital Basel, Switzerland, and Nikolas Nozica, MD, Brigham and Women's Hospital, to discuss the Nature Medicine article Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. The following is a brief summary of the study covered in the article. Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to myocardial tissue ablation without damage to adjacent structures. Here in the MANIFEST-17K study, we assessed the safety of PFA by studying the post-approval use of this treatment modality. Of the 116 centers performing post-approval PFA with a pentaspline catheter, data were received from 106 centers (91.4% participation) regarding 17,642 patients undergoing PFA (mean age 64, 34.7% female, 57.8% paroxysmal AF, and 35.2% persistent AF). No esophageal complications, pulmonary vein stenosis, or persistent phrenic palsy was reported (transient palsy was reported in 0.06% of patients; 11 of 17,642). Major complications, reported for ~1% of patients (173 of 17,642), were pericardial tamponade (0.36%; 63 of 17,642) and vascular events (0.30%; 53 of 17,642). Stroke was rare (0.12%; 22 of 17,642) and death was even rarer (0.03%; 5 of 17,642). Unexpected complications of PFA were coronary arterial spasm in 0.14% of patients (25 of 17,642) and hemolysis-related acute renal failure necessitating hemodialysis in 0.03% of patients (5 of 17,642). Taken together, these data indicate that PFA demonstrates a favorable safety profle by avoiding much of the collateral damage seen with conventional thermal ablation. PFA has the potential to be transformative for the management of patients with AF.  https://www.hrsonline.org/education/TheLead https://doi.org/10.1038/s41591-024-03114-3 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic   Contributor Disclosure(s): N. Nozica: Nothing to disclose. T. Reichlin: Nothing to disclose. This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365 https://www.heartrhythm365.org/URL/TheLeadEpisode93

Post-Cardiac Ablation Atrial Arrhythmia Monitoring   Guest: Suraj Kapa, M.D. Host: Anthony H. Kashou, M.D.   In this episode of the segment "ECG Making Waves," the listener will learn to identify the right monitoring approach for a given patient's arrhythmia considerations around ablation. They will also learn how to list specific considerations when reviewing and interpreting post-ablation arrhythmia ECGs.   Topics Discussed: What specific aspects of the ECG and ECG monitoring are important to look for after cardiac ablation? How do you approach rhythm monitoring discussions with your patients after ablation? What are potential benefits and pitfalls of different monitoring approaches for atrial arrhythmias after ablation?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

William Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Wendy Tzou, MD, FHRS, University of Colorado Anschutz Medical Campus, and Arif Elvan, MD, PhD, Klinikum Braunschweig, to discuss a partial delineation of targets for ablation of ventricular tachycardia (VT) during a stable rhythm is likely responsible for a suboptimal success rate. The abnormal low-voltage near-field functional components may be hidden within the high-amplitude far-field signal. https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.jacep.2024.04.023 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic   Contributor Disclosure(s): A.  Elvan: Honoraria/Speaking/Consulting: Abbott Medical  W. Tzou: Honoraria/Speaking/Consulting/Teaching: Medtronic, Biotronik, Mediasphere Medical, Biosense Webster, Inc., American Heart Association, Abbott, Boston Scientific, Membership on Advisory Committees: Medtronic, Inc., Biosense Webster, Inc., Kardium, BioTelemetry, Inc., Research: Abbott Medical This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365 https://www.heartrhythm365.org/URL/TheLeadEpisode92

Bruce Koplan, MD, FHRS, Brigham and Women's Hospital is joined by Erik Andrews, MD, MPH, Brigham and Women's Hospital, and Matthew Reynolds, MD, MS, FHRS, Lahey Hospital & Medical Center to discuss why Oral anticoagulation is recommended after ablation for atrial fibrillation among patients at high risk for stroke. Left atrial appendage closure is a mechanical alternative to anticoagulation, but data regarding its use after atrial fibrillation ablation are lacking.  https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2408308 Host Disclosure(s): B. Koplan: Honoraria/Speaking/Consulting: GE Healthcare    Contributor Disclosure(s): E.  Andrews: Stocks, Publicly Traded: Apple, Inc. Microsoft, Intel, Inc., Moderna Therapeutics, Fellowship Support: Boston Scientific, Medtronic, Inc. M. Reynolds: Honoraria/Speaking/Consulting: Medtronic, Edwards Lifesciences, Philips, iRhythm Technologies, Membership on Advisory Committees: Affera, Inc.   This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365 https://www.heartrhythm365.org/URL/TheLeadEpisode91

Commentary by Dr.  Jian'an Wang

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. With multiple ablation options available and still under investigation, it can be challenging to navigate the differences between them. In this episode, Dr. Tyler Sandow hosts a discussion with interventional radiologists Dr. Kirema Garcia-Reyes, Dr. Sabeen Dhand, and Dr. Kevin Burns on the various ablation options for HCC and when to use each one. Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion: https://www.cmeuniversity.com/course/take/125738" --- This podcast is supported by an educational grant from: AstraZeneca https://www.astrazeneca.com/our-therapy-areas/oncology.html With additional support from: Boston Scientific https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html --- SYNPOSIS The doctors first discuss Barcelona-Clinic Liver Cancer (BCLC) Stage A patients, where lesion size and location are key factors in deciding between ablation and transarterial therapies. They then compare cryoablation and microwave ablation, highlighting that cryoablation offers better visualization and control of the ablation zone, while microwave ablation is more effective for treating larger lesions. Dr. Burns introduces histotripsy, a noninvasive treatment that uses ultrasound energy to mechanically ablate tumors. He shares his experiences as an early adopter of this technology and discusses how intraoperative cone beam CT can help treat lesions located near critical structures or those poorly visualized on ultrasound. Finally, Dr. Garcia-Reyes and Dr. Berman provide insights into patient selection, pre-procedural imaging, and technical tips for Y90. --- TIMESTAMPS 00:00 - Introduction 02:04 - Ablation vs Y90 in BCLC A Patients 05:58 - Same-Day Y90 15:55 - Y90 for Large Tumors 17:51 - Ideal Cases for Cryoablation 19:38 - Explanation of Histotripsy 32:09 - Procedural Specifics for Histotripsy 38:21 - Technical Tips for Y90 --- RESOURCES Including the Hollow Viscera (Stomach or Bowel) within the Ice Ball during Cryoablation: A Review of Adverse Events (Abramyan et al, 2024): https://www.jvir.org/article/S1051-0443(24)00681-X/abstract

Merci à Camille d'être venue nous voir chez LEGEND ! Camille est une femme transgenre (elle est née homme devenue femme), elle a démystifié tous les clichés que l'on a sur les transgenres. Elle a abordé des thèmes comme la chirurgie, la sexualité et le regard des autres.Retrouvez Camille sur ses réseaux ⬇️Instagram ➡️ https://www.instagram.com/cam.naf?igsh=MWg4eDF4ajJqcm8zMw%3D%3D&utm_source=qrTiktok ➡️ https://www.tiktok.com/@cam.naf?_t=ZN-8tQ4rtggNjb&_r=1

Mayo Clinic's Experience with Cardioneural Ablation   Guest: Guru Kowlgi, M.B.B.S. Host: Anthony H. Kashou, MD   After listening to this podcast, the learners will develop a fundamental understanding of cardioneural ablation, as well as which patients should be referred for the procedure. Additionally, they will get a sense of the outcomes of the cardioneural ablation program at Mayo Clinic.   Topics Discussed:  Give us a quick refresher of what cardioneural ablation is, and which patient is appropriate to be referred for cardioneural ablation? What is the history of cardioneural ablation? When did you start the cardioneural ablation program at Mayo Clinic? How many cases have you done? What are the outcomes in terms of syncope-free survival and are there any complications? What differentiates Mayo Clinic from other centers performing this procedure? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.  

William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Ezim Ajufo, MD, Brigham and Women's Hospital and Victor Nauffal, MD, Brigham and Women's Hospital to discuss the Patients with rare, pathogenic cardiomyopathy (CM) and arrhythmia variants that can present with atrial fibrillation (AF). The efficacy of AF ablation in these patients is unknown. This study tested the hypotheses that: 1) patients with a pathogenic variant in any CM or arrhythmia gene have increased recurrence following AF ablation; and 2) patients with a pathogenic variant associated with a specific gene group (arrhythmogenic left ventricular CM [ALVC], arrhythmogenic right ventricular CM, dilated CM, hypertrophic CM, or a channelopathy) have increased recurrence.  https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.jacep.2024.06.035 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic   Contributor Disclosure(s): E. Ajufo: Nothing to disclose. V. Nauffal: Nothing to disclose.

Emile Daoud, MD, Deputy Editor of JACC: Clinical Electrophysiology discusses a recently published original research paper on the results of ICE-Guided isolation of the superior vena cava with pulsed field ablation.

Send us a textA groundbreaking innovation is making waves for the approximate six million Americans who suffer with atrial fibrillation (AFib). It's called pulsed field ablation. In our latest podcast episode, host Debra Schindler talks with Dr. Sunjeet Sidhu, a renowned cardiac electrophysiologist at MedStar Health, to explore the intricacies and benefits of this safer, faster, cutting-edge treatment. The number of those suffering with AFib, may even be an underestimate, but statistics show they are steadily increasing due to factors such as an aging population and the obesity epidemic. Traditionally, AFIB treatment involved thermal ablation methods, which, although effective, posed risks of collateral damage to surrounding tissues. Enter pulsed field ablation, a technique that uses ultra-short electrical pulses to target and destroy abnormal heart tissue without harming nearby structures. This method is not only safer but also more efficient, reducing procedure times significantly. Dr. Sidhu explains how pulsed field ablation works by creating a scar tissue barrier, effectively isolating the problematic areas of the heart that trigger AFIB. Unlike thermal ablation, which relies on heating or freezing tissues, pulsed field ablation uses electroporation to disrupt cell membranes, leading to cell death and scar formation. The heart cells are particularly sensitive to this type of injury, allowing for precise targeting without affecting surrounding tissues. The benefits of pulsed field ablation are manifold. Patients experience shorter procedure times, reduced anesthesia exposure, and fewer complications. Dr. Sidhu shares his firsthand experiences, noting a significant improvement in patient outcomes and satisfaction. He recounts a heartwarming story of a young mother who, after undergoing the procedure, was able to regain her quality of life and engage in activities with her children without the debilitating effects of AFIB.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Join Michael Lloyd and his guests Wendy Tzou, and Jason Jacobson as they discuss this late breaker in person at APHRS 2024 in Sydney, Australia. https://www.hrsonline.org/education/TheLead https://pubmed.ncbi.nlm.nih.gov/39331050/ Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Membership on Advisory Committees: Boston Scientific   Contributor Disclosure(s): J. Jacobson: Honoraria/Speaking/Teaching/Consulting: Zoll Medical, Vektor Medical, Inc., Abbott Medical, Research (Contracted Grants): CardioFocus, Inc., Stocks, Privately Held: Atlas 5D W. Tzou: Research (Contracted Grants): Abbott Medical, Membership on Advisory Committees: Medtronic, Inc., Biosense Webster, Inc., Kardium, BioTelemetry, Inc., Honoraria/Speaking/Teaching/Consulting: Biotronik, Mediasphere Medical, American Heart Association, Medtronic, Abbott, Biosense Webster, Inc., Boston Scientific

Have you been told your debilitating period pain is normal? Have you ever wondered if you have endometriosis? Maybe you're curious how you can find out for sure? In this conversation Dr. Karen Tang, author of It's Not Hysteria and founder of Thrive Gynecology, joins Dr. Lora Shahine to delve into the complexities of endometriosis, a common, often-misdiagnosed condition that affects many women. In this episode you'll hear the symptoms, challenges, myths, and various treatment options available.  Drs. Tang and Shahine share their experiences caring for women with endometriosis for years - Dr. Tang's perspective as a minimally invasive gynecology surgeon and Dr. Shahine as a reproductive endocrinologist and fertility specialist. They share how little they learned about endometriosis in early medical training, patient stories of doctor's dismissing obvious symptoms of the disease, and how much we still need to learn and research to help. You'll finish this episode empowered to advocate for your care and find the right doctor to help you with your next steps. In this episode you'll hear: [3:46] Understanding endometriosis [9:18] Causes and theories for endometriosis [17:24] Diagnosis & surgical confirmation [26:57] Treatment options  [35:32] Advocating for yourself and your health   Resources mentioned:  karentangmd.com It's Not Hysteria: Everything You Need to Know About Your Reproductive Heath (But Were Never Told) Follow @karentangmd on Instagram | YouTube | Tiktok  Dr. Shahine's Weekly Newsletter on Fertility News and Recommendations Follow @drlorashahine Instagram | YouTube | Tiktok | Her Books

This week we will discuss possible treatment methods for AFIB.   Atrial fibrillation (AFib) is a common type of irregular heart rhythm (arrhythmia) that occurs when the upper chambers of the heart (atria) beat chaotically and out of sync with the lower chambers (ventricles). This can lead to a variety of symptoms, including: Palpitations (a feeling of a racing or irregular heartbeat) Fatigue Shortness of breath Dizziness or lightheadedness Chest discomfort ​ AFib can increase the risk of blood clots, stroke, heart failure, and other heart-related complications. ​ Treatment Options for AFib Management of AFib focuses on controlling the heart rate and rhythm, preventing blood clots, and addressing underlying conditions contributing to the arrhythmia. The choice of treatment depends on the individual's symptoms, overall health, and risk factors. 1. Medications Medications are often the first line of treatment for AFib. These include: Rate-Control Medications Aim to slow the heart rate to a normal range. Common drugs: Beta-blockers (e.g., metoprolol), calcium channel blockers (e.g., diltiazem, verapamil), and digoxin. Rhythm-Control Medications Help restore and maintain a normal heart rhythm. Common drugs: Antiarrhythmics like amiodarone, flecainide, or sotalol. Anticoagulants (Blood Thinners) Reduce the risk of stroke by preventing blood clots. Examples: Warfarin, direct oral anticoagulants (DOACs) like apixaban (Eliquis) or rivaroxaban (Xarelto). 2. Ablation Therapy Ablation is a minimally invasive procedure aimed at correcting the electrical signals causing AFib. It is typically recommended for individuals who: Do not respond to or cannot tolerate medications. Have recurrent or persistent AFib that significantly impacts quality of life. Types of ablation: Catheter Ablation Uses thin tubes (catheters) inserted into blood vessels to deliver energy (radiofrequency or cryotherapy) to destroy small areas of heart tissue causing abnormal electrical signals. Surgical Ablation (Maze Procedure) Often performed during open-heart surgery for other conditions, creating scar tissue to block abnormal signals. Both options have high success rates, but catheter ablation is more commonly performed due to its minimally invasive nature. Choosing the Right Treatment Deciding between medications or ablation depends on factors such as: The severity and frequency of symptoms. The presence of other medical conditions. Patient preference and lifestyle. Consultation with a cardiologist or electrophysiologist is crucial to tailor treatment to the individual's needs.

A new type of catheter ablation called pulsed field ablation (PA) allows for a more precise and non-heated way to treat many cases of atrial fibrillation (A-fib). Tom McElderry, M.D., discusses the advantages of PA ablation as an alternative to radio frequency and cryotherapy ablation, the most common types. Dr. McElderry was involved with clinical trials which demonstrated that PA was faster and eliminated the risk of both phrenic nerve injury and esophageal fistula. Learn more about what this technique means for the future of A-fib treatment.

Did you miss AHA 2024? Listen here to brief discussions of the latest research. Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. N Engl J Med. DOI: 10.1056/NEJMe2414475.

Is your microwave ablation technique up to date? Dr. Ed Kim sits down with guest-host Dr. Kavi Krishnasamy to explore cutting-edge techniques in tumor ablation, with a focus on hepatocellular carcinoma (HCC) treatment with microwave. Dr. Ed Kim is the Director of Interventional Oncology and Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center. --- This podcast is supported by an educational grant from: Varian, a Siemens Healthineers company https://www.varian.com/ --- SYNPOSIS The doctors discuss microwave ablation, radiation segmentectomy, and the decision-making algorithms for choosing appropriate procedures based on lesion characteristics. Dr. Kim touches on the complexities of ablation near the diaphragm and subcapsular lesions, emphasizing the impact of practitioner skill and experience on outcomes. Recent advancements in ablation technologies, software, and device-specific versus device-agnostic applications are also highlighted, along with the importance of post-contrast scans and ultrasound skills. Dr. Kim also delves into emerging technologies such as HistoSonics, augmented reality/virtual reality, and immunotherapy synergies. The doctors underscore the need for a multidisciplinary approach for optimizing patient outcomes and pushing the field toward future innovations. --- TIMESTAMPS 00:00 - Introduction 04:28 - Standardizing Ablation Algorithms 07:51 - Suboptimal Lesion Locations 13:06 - Device Selection and Properties 22:49 - Ablation Planning Software 32:53 - Real-Time Visualization 44:48 - Biopsy and Ablation Techniques 52:14 - Future of Ablation Technology --- RESOURCES Dr. Ed Kim's Publications: https://scholars.mssm.edu/en/persons/edward-kim ACCLAIM Trial: https://www.sio-central.org/ACCLAIM-Trial A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.4093 Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial. https://ascopubs.org/doi/10.1200/JCO.2024.42.17_suppl.LBA3501 SIR welcomes results of COLLISION Trial, presented at the 2024 ASCO Annual Meeting: https://www.sirweb.org/media-and-pubs/media/news-release-archive/collision-trial-06032024/ HistoSonics: https://histosonics.com/

At temperatures hotter than the surface of the sun (>20,000K), a revolutionary physics-based process is creating the future of nanomaterials - no chemicals required. We talk to Aaike van Vugt co-founder of VSParticle and an expert in the field of spark ablation. He walks us through the process of coating materials in nanoparticles as well as its various uses. We explore what materials are suitable for the method and their pivot into nanoporous films. The Materialism Podcast is sponsored by American Elements, a leading manufacturer and supplier of materials. You can learn more about their work and services by visiting their website. This episode was sponsored by VSParticle. Be sure to check out their website to see how you can leverage their technology. More info about them can be found here. This Materialism Podcast is sponsored by Materials Today, an Elsevier community dedicated to the creation and sharing of materials science knowledge and experience through their peer-reviewed journals, academic conferences, educational webinars, and more Thanks to Kolobyte and Alphabot for letting us use their music in the show! If you have questions or feedback please send us emails at materialism.podcast@gmail.com or connect with us on social media: Instagram, Twitter. Keywords: Nanofilms Nanomaterials

Dr. Leigh Colby is my guest on the podcast today. Leigh is a dentist, a former practice owner, and has founded and been involved in multiple high-tech dental startups. He is an entrepreneur and innovator as much as he is a clinician. Leigh is also the founder of TriAgenics. TriAgenics has spent years developing third molar tooth bud ablation technology. For those who aren't familiar, this technology uses targeted microwaves and a small probe to "zap" and prevent the formation of third molars during childhood. Ablating the tooth bud would prevent the need for invasive extractions later on when the teeth are fully developed. This technology is in the final stages of FDA approval, and will quickly become available commercially as an option to our patients. In this podcast, Dr. Colby shares with us how the technology works, what the equipment looks like, the initial investment costs, and why pediatric dentists will be paving the way to make this procedure a great option for our patients.